Translate
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 27.4K other subscribers

USA finally commits 

UK and Australian figures recently confirmed that Neuroendocrine Cancer is the 10th and 7th most common cancer type.  It was great to see this post from the American Society of Clinical Oncology, albeit the USA is joining later than many other countries confirming the worst-kept secret ever – NETs are not rare.  That said, several NET specialists in the USA have been more vocal about this (one example is below), much more so than the cancer organisations (including the ones who represent us) who disappointingly market the rare theme along with the antiquated use of words such as “carcinoid” which seems rifer in USA than many other parts of the world.  USA is normally at the forefront of progress so let’s hope they will now get on with moving to the new paradigm I and many others have been suggesting for a long time.

The ASCO Post

One of the most astonishing quotes from this post is that the false perception that NETs is a rare cancer, has held back proper clinical research. ““As a result of perceived disease rarity and nonmalignant clinical course, NENs have not been subjected to rigorous clinical research, as compared with other similar tumor types”. 

This comes a couple of weeks after I publicly stated that if primary and secondary care facilities were told NETs are not rare, it might be something doctors would consider more rather than dismiss it as it’s very unlikely.  I repeat something I have said many times.  The use of ‘rare’ is holding back our awareness and has resulted in cult thinking amongst certain advocate organisations, and I’m disappointed to say that some doctors and scientific organisations also fall into this trap.  Now it seems it is also holding back rigorous clinical research.  Even just for this reason, everyone now has to stop calling it rare, stop using the carcinoid word, and stop using ridiculous animal icons.  The cult must be disbanded.

Read more by clicking here

Epidemiology of Neuroendocrine Neoplasms in the US

USA’s latest statistics as of 2020 confirms the prevalance of Neuroendocrine Neoplasms has increased by 50% over 20 years

Hot off the press, detailed analysis to follow. Latest US statistics indicate almost a quarter of a million people are living with Neuroendocrine Neoplasms (NEN) using a 20 year period 2000-2020 (complicated calculation). Previous figure was 171,321, suggesting a 50% increased prevalence.  These results suggest that NENs are increasing in incidence and prevalence; survival of patients with distant-stage disease has improved, likely reflecting improvements in therapies.  The study indicates a limitation that is well known ……. NETs may be under-reported thus leading to underestimations of their epidemiology i.e. accurate figures are probably higher.  Repeat after me – NENs are not rare.

And as this graph shows, NENs are the fastest growing cancer

Dasari A, Wallace K, Halperin DM, et al. Epidemiology of Neuroendocrine Neoplasms in the US. JAMA Netw Open. 2025;8(6):e2515798. doi:10.1001/jamanetworkopen.2025.15798

Worth pointing these latest statistics are now 5 years old.

My original blog is approaching 8 years old

Neuroendocrine Neoplasms – not as rare as you think – (ronnyallan.net)

Dr Thor Halfdanarson while attending the European NET Society conference. 

Click on the picture to read more
Click on the picture to read more
Click on the picture to read more
Click on the picture to read more

Disclaimer

I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. 

Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted.  Please check any references attached.    

Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.

Click picture to subscribe

Thanks for reading.

Ronny

Blog Facebook. Like this page please.

Personal Facebook. Like this page please.

Awareness Facebook Like this page please.

Follow me on X (formerly twitter)

Check out my online presentations

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 
Facebook
X
Pinterest
WhatsApp
Email
Buy me a cup of tea or two

Buy me a cup of tea or two? Change the number below to increment. i.e insert 2 = £8, 3 = £12, etc

Overheads to run this site, e.g. software packages, domain registration fees, software tools, misc items. Donate £4 or more so I have the fuel to keep on providing great content!

£4.00


Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe to get the latest posts sent to your email.

Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe now to keep reading and get access to the full archive.

Continue reading

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.